Full-Time

Executive Director – Pipeline CMC Technical and Strategic Lead

Confirmed live in the last 24 hours

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Senior

Somerset County, NJ, USA

Hybrid position requiring in-office presence.

Category
Computational Biology
Genomics
Biology Lab & Research
Biology & Biotech
Requirements
  • Advanced degree (MS, PhD) in biology, biomedical engineering, or equivalent with 15 years of applied technical experience and demonstrated leadership in a supervisory role
  • 15+ years of experience with process/analytical development, manufacturing and/or QC in a biotech, academic, or pharmaceutical setting
  • Extensive experience establishing manufacturing processes and QC assays to supply clinical trials for autologous and/or allogeneic clinical trials
  • Deep technical expertise in cell therapy processes and assays
  • Experience with gene editing processes and analytics is a strong plus
  • Excellent leadership, emotional intelligence, and communication skills
  • Experience with viral vectors is a plus
  • Demonstrated proficiency preparing regulatory submissions
  • Proven track record of advancing cell therapies into first in human and late-stage clinical trials
  • Creative, strategic thinking
  • Composure during challenging times
  • Strong troubleshooting skills
  • Language(s): English. Mandarin is a plus.
Responsibilities
  • Lead empowered technical teams to create and refine the CMC approaches for rapidly delivering phase-appropriate process, analytical, and gene editing components of projects with scientific excellence and patient-focus
  • Develop a vision for commercial line of sight for each product, including staging of process/analytical updates, comparability strategies, cost analyses, and technology integration
  • Direct the integration of process development, analytical development, and gene editing strategies for each pipeline project within technical development and with related functions
  • Ensure excellence in execution of CMC components of projects
  • Communicate the potential for issues and delays along with solutions and mitigation approaches
  • Direct the maintenance of a seamless relationship with research organizations and partners across the globe
  • Creatively maximize quality, efficiency, and timeline for pipeline projects while defining unknowns
  • In collaboration with the CMC Project Manager, Project Leader, and other technical leads, identify project acceleration opportunities
  • Identify relevant cross functional dependencies and constraints and work to facilitate timely resolution to achieve the desired outcomes
  • Ensure sufficient resource availability to deliver pipeline programs on time, including adjusting assignments to accommodate shifting demand
  • Direct the collaboration with in-house manufacturing to start up and operate the facility
  • Enable effective and rapid decision making with clear risks, mitigations, go/no-go criteria, and assumptions
  • Support the advancement of each project through governance endorsement at each stage-gate review
  • Maintain strong awareness of competitive landscape and adapt project approaches to maintain best/first in class
  • Establish an empowered, collaborative, science-based, agile, innovative, continuous improvement, and patient-focused culture
  • Function as a single point of accountability for CMC process, analytical and gene-editing contributions to each project
  • Build strong collaborative relationships among functional areas and create a culture of transparency, unity and engagement
  • Resolve conflict and proactively identify performance issues detrimental to the team and organization
  • Direct troubleshooting technical issues in manufacturing and quality control for clinical product supply
  • In collaboration with the innovation lead, foster creativity and continuous improvement via new innovations to deliver differentiation and superiority of our cell therapy products
  • Build science-focused high-performing teams to address development and manufacturing requirements for cell therapy products in development
  • Direct the support of technical components of CMC sections of regulatory submissions
  • Ensure compliance with regulatory requirements
  • Direct the creation and execution of strong employee development plans enabling staff readiness for future challenges delivering impactful technologies to patients

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates within the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

20%

1 year growth

47%

2 year growth

106%
Simplify Jobs

Simplify's Take

What believers are saying

  • Legend Biotech's recent European Commission approval for CARVYKTI® positions it as a leader in the multiple myeloma treatment market.
  • Strategic partnerships, such as the one with MaxCyte, enhance Legend Biotech's capabilities in cell engineering and expand its technological reach.
  • The company's commitment to transparency and investor relations, demonstrated through regular financial updates, fosters investor confidence and long-term stability.

What critics are saying

  • The competitive landscape in cell therapy and personalized medicine is intense, requiring continuous innovation to maintain market position.
  • Regulatory hurdles and the need for extensive clinical trials can delay the commercialization of new therapies, impacting revenue streams.

What makes Legend Biotech unique

  • Legend Biotech's technology-agnostic approach allows it to explore multiple innovative therapies, unlike competitors who may focus on a single technology.
  • The company's comprehensive business model, from discovery to commercialization, ensures control over the entire treatment lifecycle, providing a competitive edge.
  • Legend Biotech's strong focus on CAR-T therapies, particularly for hematological malignancies and solid tumors, sets it apart in the personalized medicine sector.

Help us improve and share your feedback! Did you find this helpful?